DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
The company operates as a pharmaceutical company. It offers adiphenine hydrochloride, epalresat, dapoxetine, deferasiox, stanozolol, and other related products.
Symed Labs Limited, is an unlisted public company incorporated on 17 August, 1998. It is classified as a public limited company and is located in Hyderabad, Telangana. It's authorized share capital is INR 2.00 cr and the total paid-up capital is INR 93.01 lac.
Read more
** All rupee values in INR crores. Based on March 2023 numbers.
29.0%
82.05%
30.76%
6.18%
None%
17.74%
-7.6
3.85
0.07
1.08
6.21
0.16
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
Credits Balance : 0
All financials
All annual returns
MoA and AoA
Latest financials
Latest annual return
MoA and AoA
Five year financials and ratios
Shareholding and group structure
Litigation and more
Everything in financial report
Peers and financials
* GST not included
** Reports & MCA filings will be based on the latest available financials.
Confirm unlock request
India
(11)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Kotak Mahindra Bank Limited
No. of Loans: 4
Total Amount : 253.6 cr
Kotak Mahindra Bank Limited
No. of Loans: 4
Total Amount : 253.6 cr cr
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Kamal Kishore Sharma | 00209430 | 2 years |
| Director | Pradip Manilal Kanakia | 00770347 | 3 years |
| Director | Kalidindi Srihari Raju | 00982034 | 3 years |
| CEO | Hari Babu Bodepudi | <HIDDEN> | 3 years |
| Director | Hari Babu Bodepudi | 01119687 | 2 years |
| Nominee Director | Vijayalakshmi Vaithianathan | 09228935 | 3 years |
| Director | Srinivas Vasireddy | 09771153 | 1 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| LUPIN PHARMACARE LIMITED |
Amalgamated
|
1.1 Cr | 1 | Maharashtra |
| SHILPA MEDICARE LIMITED |
Active
|
9.8 Cr | 1 | Karnataka |
| TEMPLECRAFT REALTY LLP |
Active
|
1.0 L | 1 | Maharashtra |
| TEMPLERIVIERE PROPERTY LLP |
Active
|
1.0 L | 1 | Maharashtra |
| TEMPLE WELLNESS VENTURES LLP |
Active
|
1.0 L | 1 | Maharashtra |
| SEQUENT SCIENTIFIC LIMITED |
Active
|
49.9 Cr | 2 | Maharashtra |
| TEMPLETREE PROPERTIES PRIVATE LIMITED |
Active
|
10.0 L | 1 | Maharashtra |
| ALIVIRA ANIMAL HEALTH LIMITED |
Active
|
47.8 Cr | 2 | Maharashtra |
| VIYASH LIFE SCIENCES PRIVATE LIMITED |
Active
|
334.4 Cr | 5 | Telangana |
| FAISA FINANCIAL P LTD |
Active
|
52.0 L | 1 | Maharashtra |
| TEMPLE WELLNESS VENTURES INDIA PRIVATE LIMITED |
Active
|
10.0 L | 1 | Maharashtra |
| JM FINANCIAL LIMITED |
Active
|
95.6 Cr | 1 | Maharashtra |
| SONA BLW PRECISION FORGINGS LIMITED |
Active
|
621.3 Cr | 1 | Haryana |
| HEALTHCARE GLOBAL ENTERPRISES LIMITED |
Active
|
139.4 Cr | 1 | Karnataka |
| CAMLIN FINE SCIENCES LIMITED |
Active
|
16.7 Cr | 1 | Maharashtra |
| BRITANNIA INDUSTRIES LTD |
Active
|
24.1 Cr | 1 | West Bengal |
| TORRENT GAS LIMITED |
Active
|
1,675.0 Cr | 1 | Gujarat |
| S.V. LABS PRIVATE LIMITED |
Active
|
6.0 Cr | 2 | Telangana |
| VINDHYA PHARMA (INDIA) PRIVATE LIMITED |
Active
|
1.9 Cr | 3 | Telangana |
| POKEPOLA ENTERPRISES LLP |
Active
|
25.0 Cr | 1 | Telangana |
| VANDANA LIFE SCIENCES PRIVATE LIMITED |
Active
|
1.9 Cr | 2 | Telangana |
| APPCURE LABS PRIVATE LIMITED |
Active
|
51.8 L | 3 | Telangana |
| ASTRIX LABORATORIES LIMITED |
Amalgamated
|
4.5 Cr | 1 | Telangana |
| VIYASH LABORATORIES PRIVATE LIMITED |
Strike Off
|
10.0 L | 1 | Telangana |
| VIYASH PHARMACEUTICALS PRIVATE LIMITED |
Strike Off
|
10.0 L | 1 | Telangana |
| GENINN LIFE SCIENCES PRIVATE LIMITED |
Active
|
10.0 L | 1 | Telangana |
| VINDHYA ORGANICS PRIVATE LIMITED |
Active
|
4.1 Cr | 1 | Telangana |
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| Medsy FZE | United Arab Emirates | - | - |
| CHEMI PACK (INDIA) PRIVATE LIMITED | Telangana | 2007 | ₹ 2.5 Cr |
| SRI CHENNA KESAVA BIO ENERGY PRIVATE LIMITED | Telangana | 2011 | ₹ 4.5 L |
| HETSYM ESTATES AND REALTORS PRIVATE LIMITED | Telangana | 2005 | ₹ 1.1 Cr |
| HETSYM BIO CHEMICALS PRIVATE LIMITED | Telangana | 2008 | ₹ 11.5 L |
The incorporation date of SYMED LABS LIMITED is 17 August, 1998
The authorized share capital of SYMED LABS LIMITED is INR ₹ 2.0 Cr.
The paid-up capital of SYMED LABS LIMITED is INR ₹ 93.0 L.
The registered address of SYMED LABS LIMITED is Plot No. 290, Srivallis Corporate, Road No. 6, Kakatiya Hill s, Madhapur Shaikpet Hyderabad Telangana - 500081
The CIN number of SYMED LABS LIMITED is U24231TG1998PLC029961.
Expand
Delete
Collapse
See
details
It will take sometime. Please come back in 10
minutes
